As we witness a surge in later-stage clinical trials within the gene therapy industry, the spotlight on comparability has never been brighter. That's why we're thrilled to announce the return of the 4th Gene Therapy Comparability Summit, taking place in Boston, MA, February 13-15. This event is your gateway to uncovering how to implement effective comparability […]

100+ Technical mRNA Specialists | 35+ Expert Speakers As access to faster and higher-throughput analytical methods becomes increasingly vital, it is critical that we employ superior analytical approaches for mRNA-based therapeutics and vaccines to ensure high quality and effective drugs are approved, whilst adhering to regulatory guidelines. The 3rd mRNA Analytical Development Summit returns to Boston in February to […]

The 6th Annual CRISPR AgBio Congress is back on February 20-22, 2024 (Raleigh, NC). The dedicated congress that unites industry stakeholders across Agbiotech, big seed, distributors, and investors, to assess this new regulatory terrain, examine recent scientific breakthroughs, and strategize the journey of CRISPR products from editing to delivery, field to shelf. Discover the full […]

Viral Vector Process Development & Manufacturing Summit Create Qualitative, Accessible Treatments for Patients Following Ring Therapeutics’ injection of $86.5m to enhance novel viral vector capabilities, and BMS’s viral vector facility coming online, the viral vector market is forecasted to reach $12.8bn – not only in cell and gene therapies but also viral-vector-based vaccines and immunotherapies. […]

From Bristol Myers Squibb expanding their cardiovascular partnership with Avidity Biosciences' antibody-oligonucleotide conjugate technology, to Nurix and Seagen collaborating on a targeted protein degradation conjugate, there is now a staggering amount of investment and collaboration in the novel conjugates space. As highlighted above, drug developers are pushing the boundaries of traditional ADCs by designing and developing novel targeting formats and payloads. Whilst the likes of VincerX Pharma, Dyne Therapeuitcs and Alnylam are now […]

Cell therapy continues to transform the oncology field, and this year has also seen the translation of cell therapies’ curative potential into the autoimmune space. Providing your team with exclusive access to cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe is your must-attend forum to stay at the forefront of these innovations.   300+ […]

The Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Actively engage with the likes of Merck, Pfizer, SNIPR Biome, Locus Biosciences, Phiogen, AMR Action Fund and 90+ phage experts to demonstrate positive clinical data and patient outcomes. Take advantage of this unique opportunity to be a part of the dialogue, […]

With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has skyrocketed in recent years. The DNA Process Development & Manufacturing Summit is the only industry-dedicated forum to focus on topics such as DNA construct design, sequencing technology, […]

We find ourselves at the cutting edge of oncology innovation, with the ADC field booming with excitement due to the constant eflux of clinical progress and a plethora of high-value collaborations. As such the 14th World ADC London 2024 returns this March as a crucial touchpoint for all antibody drug conjugate developers across Europe. This meeting is the place […]

Returning for the seventh year, the 7th Antigen-Specific Immune Tolerance Summit (March 18 - 20, 2024 | Boston, MA) will lean into the industry’s key challenges from details of T-cell assays in preclinical and larger clinical studies; to pioneering CAR-Treg, mRNA-LNP, biologic, peptide, approaches and updates on proof-of-concept and ongoing clinical programs. This is the highest value […]

“The translational impact and nature of the work that was being presented were outstanding. You get a lot of insights from your peers regarding their experience interacting with the regulatory agencies” – ONK Tx The 9th Innate Killer Summit is designed for experts striving to realize the clinical potential of NK–based therapies from early discovery to later stages […]

The Definitive Industry Forum for CKD Drug Development Advance More Personalized Therapies for Rare & Common Kidney Diseases The 6th CKD Drug Development Summit is the definitive forum for KOLs, industry experts, and regulators to bring kidney innovation onto the next generation of drug development, uniting 200+ biopharma stakeholders, from scientific research to clinical development […]

In the dynamic cell therapy landscape, the challenge of potency assay development looms large, as exemplified by clinical holds experienced by Mesoblast and Verve Therapeutics in recent years. At the 3rd Cell Therapy Potency Assay Summit, we bring together over 120 analytical, quality control, and regulatory experts including esteemed organizations like BMS, J&J, Atara Biotherapeutics, Fate Therapeutics, Health […]

Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise. Back in Boston as the only industry forum defining global regulations for EAP and your definitive networking opportunity to connect with managed access teams from other leading […]

The 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit is returning to Boston this upcoming March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient […]

Step into the 2nd Targeted Intracellular Delivery Summit, a thrilling exploration of cutting-edge advancements in drug delivery. This year, we redefine possibilities, venturing beyond traditional boundaries with a focus on cellular biology and intracellular mechanisms. Optimize drug delivery, overcome endosomal challenges, and expand therapies beyond the liver with in-depth case studies and a Pre-Conference Workshop […]

Neuroimmunology targets in neurodegeneration are hotter than ever. Capturing biopharma’s latest research spanning discovery to early clinical development, the 6th Neuroimmunology Drug Development Summit is the industry-choice, comprehensive forum dedicated to translating neuroinflammatory-targeted therapeutics into clinical trials. What are the top features to look forward to in 2024? Doubled pre-conference workshop content, with 6 deep-dive […]

As the cell therapy field rapidly expands, keeping ahead of the race by creating a visible and robust supply chain has never been more critical to ensure you have the skills and strategy to develop into the next stage of your pipeline. Join us at the 5th Supply Chain & Logistics for Cell Therapies Summit […]

The 5th Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech, neuro-oncologists and academic KOLs to unite alongside a dedicated panel of investors under the common goal to breakthrough GBM barriers to accelerate the practical translation and clinical development of emerging therapeutics for glioblastoma and CNS tumor patients. Discover innovative approaches to surpassing […]

Accelerate patient value. Pioneer healthcare’s transformation.  Healthcare reforms are finally paving the way to affordable access to medicines, yet this progress threatens the development of future life-saving therapies. The moment is now to prove ourselves as a trusted industry ally and the ultimate safe harbor for patients. The key? Delivering aligned value to HCPs, patients, payers and […]

This past year has seen more gene therapies approved by the FDA than the previous five years combined, and almost triple the number of clinical trials in gene therapy have been initiated in H1 of 2023 compared to the same time frame in the previous year. To maximize the value of your late-stage gene therapy […]

The Measuring Patient Engagement Summit is the definitive conference for practical answers. This event will act as the honeypot gathering for leading patient engagement experts to share their latest experiences of how they are successfully measuring patient engagement to: inform decision making in improving patient engagement, quantify the impact of patient engagement on recruitment and retention, and ensure the most […]

The 3rd ADC Analytical Development Summit is your only industry-dedicated meeting providing you with the key insights to ensure you are developing a high-quality ADC product within regulatory boundaries. Next year’s program promises to give you even more focused content to better quantify DAR and drug distribution, overcome species separation challenges, and better utilize impurity assays to measure free-linker drug and process-related […]

Discover & Shape the Future of Biologics & Antibody Therapies at the 4th Fc-Mediated Function Summit FINAL 5 PASSES REMAINING – Register Now at https://ter.li/g5st7q At the intersection of groundbreaking research, clinical innovation, and collaborative networking, the 4th Fc-Mediated Function Summit stands as a beacon for advancing the frontier of FcRn, FcγR, and IgG therapeutics. Our mission is to supercharge […]

Discover the forefront of gene therapy at the 4th Gene Therapy for Muscular Disorders Summit (April 16-18, Boston). Following the groundbreaking approval of Sarepta's DMD gene therapy in June 2023, our April 2024 gathering explores key challenges in translating research into clinical breakthroughs. With a sharp focus on safety and efficacy, we unite experts to […]

SAE Media Group's 11th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2024 to bring you the latest advances in the combination product drug delivery space. The 2024 conference will be bigger and better than ever, bringing you 3 days of expertise, comprising of a pre-conference focus day exploring the advances […]

The 5th TCR-based Therapies for Solid Tumors Summit returns is back as the exclusive gathering where TCR pipelines take center stage. It serves as the premier platform for networking with biopharma industry leaders dedicated to expediting the clinical and commercial development of TCR-based therapeutics. This summit serves as the epicenter for exploring these transformative advancements, […]

As European biopharma seek regulatory clarity to progress their mRNA process development and manufacturing, the 2nd mRNA Process Development & Manufacturing Summit Europe returns to help you improve and optimise purification processes, platforms for circular and saRNAs and drug product formulation. Where: Crowne Plaza Frankfurt – Congress Hotel, Frankfurt, Germany When: 23-25th April, 2024 Website: https://ter.li/d3ggdb […]

In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera's FDA IND approval to Brexogen's recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements. The Exosome Characterization […]

Positioned in the goldilocks spot between small molecules and biologics, peptide therapeutics have undergone an exciting uphill trajectory within the last decade. Fuelled by advances in synthesis and screening technologies, together with novel design and delivery strategies to surmount their inherent drawbacks, this modality is showing new levels of promise. The momentum behind this exciting […]